(PDF) Pharmacodynamics and Therapeutic Usage of Recombinant

Pharmacodynamics and Therapeutic Usage of Recombinant Human Erythropoietin (SNB-5001) in Animal Models.

Folia Pharmacologica Japonica - Japan

doi 10.1254/fpj.99.213

Full Text

Abstract

Available in full text

Categories

Date

January 1, 1992

Authors

Hiroaki MASUNAGA

Masumi HIRABAYASHI

Publisher

Japanese Pharmacological Society

Related search

Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot Trial

English

Recombinant Human Erythropoietin vs Transfusions in the Treatment of Anemia of Prematurity

Archives of Pediatrics & Adolescent Medicine

English

Improvement of Cognitive Functions in Chronic Schizophrenic Patients by Recombinant Human Erythropoietin

Molecular Psychiatry

Molecular Neuroscience

Molecular Biology

English

Non-Cardiac Benefits of Human Recombinant Erythropoietin in End Stage Renal Failure and Anaemia.

Archives of Disease in Childhood

English

A Trial of Blood Conservation in Cardiovascular Surgery. Effect of Recombinant Human Erythropoietin.

Japanese Journal of Cardiovascular Surgery

English

Effect of Erythropoietin on Human Tumor Growth in Xenograft Models

Molecular Medicine Reports

Molecular Biology

Cancer Research

Molecular Medicine

English

Effect of Human Recombinant Erythropoietin Before Autologous Blood Donation in Gastrointestinal Cancer Surgery.

Japanese Journal of Gastroenterological Surgery

Gastroenterology

English

Response of Anaemia in Rheumatoid Arthritis to Treatment With Subcutaneous Recombinant Human Erythropoietin.

Annals of the Rheumatic Diseases

Molecular Biology

English

Recombinant Human Erythropoietin Influences Revascularization and Healing in a Rat Model of Random Ischaemic Flaps

Acta Dermato-Venereologica

English